Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Immunological Reviews|December 17, 2013
Re-adapting T cells for cancer therapy: from mouse models to clinical trialsIngunn M Stromnes, Thomas M Schmitt, Aude G Chapuis, et al.Oncotarget|September 9, 2017
The miR-106a~363Xpcl1 miRNA cluster induces murine T cell lymphoma despite transcriptional activation of the p27Kip1 cell cycle inhibitorDaniel A Kuppers, Thomas M Schmitt, Harry C Hwang, et al.Nature Biotechnology|November 7, 2017
Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitroThomas M Schmitt, David H Aggen, Kumiko Ishida-Tsubota, et al.Immunity|June 11, 2004
Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineagesHelen E Porritt, Lynn L Rumfelt, Sahba Tabrizifard, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2009
Adoptive immunotherapy of disseminated leukemia with TCR-transduced, CD8+ T cells expressing a known endogenous TCRMichelle L Dossett, Ryan M Teague, Thomas M Schmitt, et al.Plos One|October 27, 2022
Perceptions of ecosystem services: Comparing socio-cultural and environmental influencesMiriam Thiemann, Rebekka Riebl, Maria Haensel, et al.Nature Immunology|March 23, 2004
Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitroThomas M Schmitt, Renée F de Pooter, Matthew A Gronski, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2011
Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8Jennifer D Stone, David H Aggen, Adam S Chervin, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Notch signaling requires GATA-2 to inhibit myelopoiesis from embryonic stem cells and primary hemopoietic progenitorsRenée F de Pooter, Thomas M Schmitt, José Luis de la Pompa, et al.Blood|May 16, 2013
Enhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selectionThomas M Schmitt, David H Aggen, Ingunn M Stromnes, et al.Pageof 4